Mannkind (MNKD) Times Interest Earned (2010 - 2026)
Mannkind (MNKD) reported Times Interest Earned of -$0.22 for Q1 2026, down 104.64% year-over-year from $4.8 in Q1 2025, and up 78.15% quarter-over-quarter from -$1.02 in Q4 2025.
Mannkind (MNKD) Times Interest Earned (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Times Interest Earned data on file, last reported at -$0.22 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$0.22, down 104.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.89 (down 83.98% YoY), and the FY2025 annual result was $2.81, down 53.69% from the prior year.
- Times Interest Earned rose to -$0.22 in Q1 2026 per MNKD's latest filing, from -$1.02 in the prior quarter.
- Over five years, Times Interest Earned peaked at $18.59 in Q2 2025 and troughed at -$7.74 in Q1 2022.
- A 5-year average of $3.14 and a median of $1.81 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned plunged 706.12% in 2022, then jumped 996.25% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$4.55 in 2022, then soared by 164.47% to $2.94 in 2023, then soared by 477.86% to $16.96 in 2024, then sank by 106.01% to -$1.02 in 2025, then jumped by 78.15% to -$0.22 in 2026.
- Business Quant data shows MNKD's Times Interest Earned at -$0.22 in Q1 2026, -$1.02 in Q4 2025, and $13.85 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -1.02 |
| Sep 30, 2025 | 13.85 |
| Jun 30, 2025 | 18.59 |
| Mar 31, 2025 | 4.80 |
| Dec 31, 2024 | 16.96 |
| Sep 30, 2024 | 7.08 |
| Jun 30, 2024 | 2.75 |
| Mar 31, 2024 | 6.51 |
| Dec 31, 2023 | 2.94 |
| Sep 30, 2023 | 1.81 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | -2.15 |
| Dec 31, 2022 | -4.55 |
| Sep 30, 2022 | -3.42 |
| Jun 30, 2022 | -3.08 |
| Mar 31, 2022 | -7.74 |
| Dec 31, 2021 | -8.66 |
| Sep 30, 2021 | -2.35 |
| Jun 30, 2021 | -3.23 |